Screening for fall risk in stroke patients using brain activity monitoring
Screening Diagnosis of Fall Risk After Stroke and Initial Intervention: A Functional Near-infrared Spectroscopy (fNIRs) Study
This study is testing if monitoring brain activity can help identify fall risks in stroke patients and if using feedback from muscle activity can improve their ability to stand up safely.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | First Affiliated Hospital of Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing) |
| Trial ID | NCT06062407 on ClinicalTrials.gov |
What this trial studies
This study utilizes functional near infrared spectroscopy (fNIRs) to assess the risk of falls in patients who have experienced a stroke. Participants undergo two models of simultaneous fNIRs-EEG testing during the sit-to-stand process, first without intervention and then with biofeedback based on electromyographic (EMG) data. The study aims to compare brain activation and connectivity between stroke patients and healthy individuals, as well as to preliminarily validate the effectiveness of EMG feedback training for improving sit-to-stand transitions in post-stroke patients.
Who should consider this trial
Good fit: Ideal candidates include stroke patients aged 18-85 who can complete a sit-to-stand transition and follow instructions.
Not a fit: Patients with serious mental illness, those unable to tolerate the testing, or pregnant/lactating women may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved fall prevention strategies for stroke patients, enhancing their safety and quality of life.
How similar studies have performed: While the use of fNIRs in this context is relatively novel, similar studies have shown promise in assessing brain activity related to motor functions in stroke rehabilitation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Stroke patients 1. Diagnosis of stroke confirmed by neuroimaging (CT or MRI) evaluation 2. 18-85 years old 3. Able to complete the sit-to-stand transition 4. Able to follow instructions to complete the trial 5. Patients who signed an informed consent form. Healthy Subjects: 1. No abnormalities on cranial fMRI examination 2. 18-85 years old 3. Able to complete the sit-to-stand transition 4. Able to follow instructions to complete the trial 5. not taking medications. 6. Subjects who signed an informed consent form Exclusion Criteria: Stroke patients: 1. Inability to tolerate the test due to organic diseases 2. Serious mental illness that prevents them from cooperating with or tolerating the trial 3. Pregnant or lactating women 4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction. Healthy Subjects: 1. Inability to tolerate the test due to organic diseases 2. Serious mental illness that prevents them from cooperating with or tolerating the trial. 3. Pregnant or lactating women 4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction
Where this trial is running
Chongqing
- Department of Rehabilitation Medicine, the First Affiliated Hospital of Chongqing Medical University — Chongqing, China (Recruiting)
Study contacts
- Study coordinator: Zheng Yang
- Email: 2022140041@stu.cqmu.edu.cn
- Phone: 023-89011334
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.